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Abstract
Background: Recent studies have reported an increased incidence of both aortic aortic stiff-
ness and left ventricular (LV) systolic and diastolic dysfunction in patients with inflammatory 
bowel disease (IBD). However, the association between aortic stiffness and the LV function has 
not been fully defined. We aimed to investigate the relationship between aortic stiffness and the 
LV function in IBD patients.
Methods and Results: Seventy-two patients with IBD (56 cases of ulcerative colitis and  
16 cases of Crohn’s disease) and 50 healthy controls were consecutively enrolled in this study. 
The LV systolic and diastolic functions were assessed using conventional echocardiographic 
techniques, including tissue Doppler echocardiography. The degree of aortic strain and disten-
sibility were calculated based on the aortic diameters measured on M-mode echocardiography 
at the level of 3 cm above the aortic valve and the blood pressure values obtained on sphyg-
momanometry. There were significant differences between the IBD and control group in the 
degree of aortic strain and distensibility. Significant differences were also observed between 
the patient and control groups in the parameters of the LV systolic and diastolic functions. 
Moreover, aortic stiffness was found to be associated with the LV function in the patient group.
Conclusions: There is a significant relationship between aortic stiffness and LV systolic and 
diastolic dysfunction in patients with IBD, based on the findings of this study. The parameters 
of aortic elasticity measured according to 2-dimensional echocardiographic methods can be 
beneficial for predicting early cardiovascular risk in cases of IBD. (Cardiol J 2016; 23, 2: 202–210)
Key words: aortic stiffness, left ventricular function, inflammatory bowel disease, 
tissue Doppler echocardiography
Introduction
Inflammatory bowel disease (IBD), which is 
commonly diagnosed in young adults, is composed 
of a group of inflammatory diseases of the colon and 
small intestine occurring in genetically predisposed 
individuals. Ulcerative colitis (UC) and Crohn’s dis-
ease (CD) represent the two major forms of IBD, 
both of which have a chronic course and are charac-
terized by episodes of remission and exacerbation. 
Recent studies have reported that, despite the fact 
that the prevalence of traditional cardiovascular (CV) 
risk factors is lower than in the general population 
[1–3], the risk of CV events is increased in IBD 
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patients [4, 5], suggesting that additional mecha-
nisms, such as inflammation, could be responsible 
for the excess CV risk observed in IBD cases. In 
these subjects, the low CV risk associated with the 
low prevalence of traditional CV risk factors may 
be at least partly counterbalanced by the increased 
CV risk associated with chronic inflammation. In 
cases of IBD, inflammation and atherosclerosis are 
closely linked. Inflammation mediates its effects on 
atherosclerosis via both modulating traditional risk 
factors and directly affecting the vessel wall [6].
In a recent small study, it was shown that arte-
rial stiffness is increased in IBD patients [7]. The 
role of arterial stiffness in the development of CV 
diseases is well known [8]. In particular, the pres-
ence of arterial stiffness in large arteries, such as the 
aorta, has been reported to be the best predictor of 
CV morbidity and mortality [9]. Although there are 
several parameters used in assessments of arterial 
stiffness, the degree of stiffness can be evaluated 
with echocardiography using relatively simple, 
non-invasive methods. Both aortic distensibility 
(AD) and aortic strain (ASt) are elasticity indices for 
the aorta and reflect the degree of aortic stenosis 
(AS) [8, 10]. While AS is known to be related to 
atherosclerosis, its association with cardiac systolic 
and diastolic functions in cases of IBD has not been 
fully evaluated. In this study, we aimed to evaluate 
the association of AS with the left ventricular (LV) 
systolic and diastolic functions in patients with IBD.
Methods
Study patients and protocol
A total of 72 patients with IBD (56 patients 
with UC and 16 patients with CD, ages 18–50 
years) and 50 matched healthy controls treated 
between December 2013 and October 2014 were 
consecutively enrolled into this prospective study. 
The diagnosis of IBD was confirmed using estab-
lished criteria consisting of clinical, radiological, 
endoscopic and histological findings. The medical 
history of each patient, including the disease dura-
tion and medications, was collected, and a routine 
physical examination was conducted. Patients with 
an age over 50 or under 18 years, structural heart 
disease, overt CV disease based on the presence 
of abnormal echocardiographic findings, complaints 
related to peripheral or coronary artery disease and 
a history of cerebrovascular disease, hypertension 
(HT) as defined by a blood pressure (BP) of at least 
140/90 mm Hg and/or the use of anti-hypertensive 
medications, hyperlipidemia and/or the use of lipid-
lowering medications, diabetes mellitus (DM) and/ 
/or the use of anti-diabetic medications, pulmonary 
disease or neoplastic or chronic systemic diseases 
were excluded from this study. All subjects were 
informed about the study protocol, and written in-
formed consent was obtained from each volunteer. 
Approval for the study protocol was obtained from 
the local Ethics Board. 
Echocardiography
Conventional echocardiographic meas-
urements. The echocardiographic evaluations 
of all subjects were performed by a single, ex-
perienced cardiologist who was not informed of 
the clinical or laboratory findings of the patients. 
The echocardiographic examinations were car-
ried out using a 2.5- to 3.5-MHz transducer with 
the Vingmed System 7 (Vivid 7, GE, Horten, 
Norway). M-mode echocardiography and a quanti-
tative analysis were conducted using parasternal 
long axis images based on data provided by the 
American Society of Echocardiography [11]. 
The LV systolic and diastolic functions were 
analyzed using standard two-dimensional (2D) 
echocardiography, M-mode echocardiography, 
pulsed-wave (PW) echocardiography and tissue 
Doppler echocardiography (TDE). The LV end-
diastolic diameter (LVEDD) and LV end-systolic 
diameter (LVESD), left atrium (LA) diameter, 
interventricular septum (IVS) and posterior 
wall thicknesses were obtained using M-mode 
echocardiographic tracings under the guide of 
2D imaging. The left ventricular ejection fraction 
(LVEF) was calculated according to the biplane 
modified Simpson method. The mitral inflow 
early diastolic wave (E), late diastolic wave (A), 
E/A ratio, deceleration time (DT), isovolumetric 
contraction time (IVCT), ejection time (ET) and 
isovolumetric relaxation time (IVRT) were meas-
ured on PW echocardiography, and the myocardial 
performance index (MPI) was calculated by divid-
ing the sum of IVRT and IVCT by ET.
Tissue Doppler imaging
The myocardial systolic wave (S’), early dias-
tolic myocardial wave (E’), late diastolic myocardial 
wave (A’), E’/A’ ratio, myocardial IVCT (IVCTm), 
myocardial ET (ETm), IVCTm/ETm ratio and 
myocardial IVRT (IVRTm) were measured on color 
TDE conducted on respectively lateral parts of the 
mitral annulus. MPI was calculated by dividing the 
sum of IVCTm and IVRTm by the ETm value. The 
E/E’ ratio was measured by dividing the mitral in-
flow early diastolic wave (E) by the early diastolic 
myocardial wave (E’).
www.cardiologyjournal.org 203
Abdullah Nabi Aslan et al., Left ventricular function in inflammatory bowel disease
Measurement of aortic stiffness
The diameter of the ascending aorta was 
measured from the same view on the M-mode 
tracing at a level 3 cm above the aortic valve. The 
systolic aortic diameter (AoSD) was measured at 
the maximal anterior motion of the aorta, whereas 
the diastolic aortic diameter (AoDD) was measured 
at the peak of the QRS complex on the simultane-
ously recorded electrocardiogram. The systolic BP 
(SBP) and diastolic BP (DBP) values were meas-
ured on both arms using an external sphygmoma-
nometer, and the higher value was recorded. The 
pulse pressure (PP) was calculated as SBP minus 
DBP. The degree of ASt (%) was calculated as 
(AoSD – AoDD)/AoDD, and AD (10–6 cm2 × dyn–1) 
was calculated as (2 × ASt)/PP.
Statistical analysis
The data analysis was performed using the 
SPSS 17 software package (Statistical Package 
for Social Sciences Inc., Chicago, IL, USA). The 
normality of the distribution of continuous vari-
ables was analyzed using the Shapiro-Wilk test. 
Descriptive statistics are expressed as the mean 
± standard deviation or median (minimum–maxi-
mum) for continuous variables and as the number 
of observations and percentages (%) for categorical 
variables. The significance of the differences in the 
measurements obtained for the control and patient 
groups was analyzed using Student’s t-test or the 
Mann-Whitney U test. We used ANOVA and a post 
hoc analysis for multiple comparisons between the 
control group, IBD group, UC group and CD group. 
The Pearson c2 test was used to compare categori-
cal variables. A Pearson’s analysis was used to 
calculate the correlation coefficient. A p value of 
< 0.05 was considered to be statistically significant.
Results
Demographic characteristics of the subjects
The characteristics of the study populations 
are presented in Table 1. The IBD patients were 
relatively young (mean age: 41.6 ± 11.7 years) and 
predominantly male (46 [63%] men and 26 [37%] 
women). Among the IBD patients, 78% (n = 56) 
had UC and 22% (n = 16) had CD. All IBD patients 
were in remission. The mean disease duration was 
68.2 ± 18.7 months (minimum to maximum: 1–240 
months). Of the IBD patients, 84% (n = 60) were 
Table 1. The demographic characteristics of the subjects in the study groups.
Variables IBD group (n = 72) Control group (n = 50) P
Age [years] 41.6 ± 11.7 39.9 ± 7.9 0.358
Gender (male/female) 46/26 29/21 0.515
Body mass index [kg/m2] 27.6 ± 4.5 27.0 ± 3.5 0.429
Systolic BP [mm Hg] 121.3 ± 12.2 118.7 ± 11.4 0.235
Diastolic BP [mm Hg] 74.6 ± 8.5 73.7 ± 8.1 0.551
Pulse [bpm] 76.8 ± 11.5 78.8 ± 10.6 0.341
Smokers [%] 13.9 20 0.374
Fasting blood glucose [mg/dL] 93.2 ± 9.9 95.4 ± 11.1 0.265
Total cholesterol [mg/dL] 173.6 ± 41.1 186.0 ± 37.7 0.093
LDL cholesterol [mg/dL] 102.4 ± 32.5 117.7 ± 30.2 0.010
HDL cholesterol [mg/dL] 47.3 ± 17.3 46.2 ± 9.5 0.681
Triglyceride [mg/dL] 117.1 ± 66.1 124.8 ± 69.7 0.537
Sedimentation [mm/h] 20.0 ± 20.9 11.8 ± 5.2 0.008
C-reactive protein [mg/L] 0.79 ± 1.7 0.54 ± 0.41 0.337
LVEDD [mm] 44.4 ± 3.4 44.5 ± 3.1 0.865
LVESD [mm] 26.5 ± 2.9 25.5 ± 2.7 0.074
Left atrium diameter [mm] 33.8 ± 3.8 33.7 ± 4.2 0.876
Interventricular septum [mm] 9.2 ±1.2 9.0 ± 1.0 0.281
Posterior wall [mm] 9.2 ± 1.1 8.8 ± 1.0 0.103
Left ventricular ejection fraction [%] 65.1 ± 0.1 65.3 ± 3.9 0.517
IBD — inflammatory bowel disease; BP — blood pressure; LDL — low-density lipoprotein; HDL — high-density lipoprotein, LVEDD — left  
ventricular end-diastolic diameter; LVESD — left ventricular end-systolic diameter
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Table 2. Pulse-wave echocardiographic measurements of the study groups.
Variables Controls 
(n = 50)
Total IBD patients 
(n = 72)
UC patients  
(n = 56)




0.90 ± 0.14 0.66 ± 0.16 
(p < 0.001)
0.65 ± 0.17 
(p < 0.001)
0.70 ± 0.16 
(p < 0.001)
Late diastolic  
wave (A) [m/s]
0.74 ± 0.10 0.79 ± 0.19 
(p = 0.072)
0.79 ± 0.19 
(p = 0.093)
0.80 ± 0.20 
(p = 0.097)
E/A ratio 1.23 ± 0.20 0.90 ± 0.34 
(p < 0.001)
0.90 ± 0.35 
(p < 0.001)
0.92 ± 0.28 
(p < 0.001)
E/E’ ratio 0.06 ± 0.01 0.09 ± 0.02 
(p = 0.001)
0.09 ± 0.02 
(p < 0.001)




168 ± 28 216 ± 42 
(p < 0.001)
218 ± 41 
(p < 0.001)
210.2 ± 44.4 
(p < 0.001)
IVCT [ms] 69.7 ± 11.8 64.8 ± 13.4 
(p = 0.042)
65.3 ± 13.7 
(p = 0.083)
63.2 ± 12.4 
(p = 0.066)
Ejection time [ms] 286.2 ± 29.8 286.3 ± 27.5 
(p = 0.984)
287.3 ± 27.3 
(p = 0.854)
282.5 ± 29.2 
(p = 0.688)
IVRT [ms] 70.0 ± 13.8 86.3 ± 22.3 
(p < 0.001)
87.1 ± 22.9 
(p < 0.001)




0.49 ± 0.08 0.53 ± 0.12 
(p = 0.070)
0.53 ± 0.12 
(p = 0.056)
0.51 ± 0.12 
(p = 0.425)
IBD — inflammatory bowel disease; UC — ulcerative colitis; CD — Crohn’s disease; IVCT — isovolumetric contraction time; IVRT — isovolu-
metric relaxation time
treated with salicylates only, whereas the remaining 
16% (n = 12) were treated with salicylates and ster-
oids or immunosuppressors. The healthy controls 
were well matched, and there were no significant dif-
ferences between the IBD patients and healthy con-
trols with respect to age, gender, body mass index 
(BMI), SBP, DBP, heart rate or the total cholesterol, 
plasma triglyceride (TG), high-density lipoprotein 
cholesterol (HDL-C) and C-reactive protein (CRP) 
levels. However, the low-density lipoprotein cho-
lesterol (LDL-C) levels were significantly higher in 
the controls than in the IBD group (117.7 ± 30.2 vs. 
102.4 ± 32.5 mg/dL, respectively, p = 0.010). The 
erythrocyte sedimentation rate was also significantly 
higher in the IBD group than in the controls (20.0 ± 
± 20.9 vs. 11.8 ± 5.2 mm/h, p = 0.008).
Echocardiography
No statistically significant differences were 
detected between the patient and control groups 
with respect to the LVEDD, LVESD, LA diameter, 
IVS and posterior wall thicknesses and LVEF.
The PW echocardiographic measurements 
in the study groups are demonstrated in Table 2. 
Accordingly, the IVRT and DT values were sig-
nificantly longer and the E waves, E/A ratio and 
IVCT values were significantly lower in the pa-
tient group; however, there were no statistically 
significant differences in the other parameters. 
A subgroup analysis of these parameters showed 
the same results for the UC and CD groups vs. 
the controls, except for IVCT, which, although 
lower than that seen in the controls, did not 
reach statistical significance in either the UC or 
CD groups. The PW TDE measurements of the 
septal wall in both groups are presented in Table 3. 
According to these results, the S’, E’, A’ and E’/ A’ 
values were significantly lower, while the IVRTm, 
IVCTm and MPI values were significantly higher in 
the patients group than in the controls. In addition 
to these findings, the E/E’ ratio, a well-validated 
parameter of the diastolic function was found to be 
significantly higher in the patients with IBD than 
in the controls. Although mostly similar findings 
were observed in the subgroup analysis of the UC 
and the CD groups, the rise in the E’/A’ ratio was 
not statistically significant (p = 0.079) in the CD 
group versus the controls.
Indices of aortic stiffness
The aortic elastic parameters are shown in 
Table 4. The degree of ASt (7.38 ± 2.6 vs. 15.1 ± 
± 4.5; respectively, p < 0.001) and AD (3.3 ± 
± 1.4 vs. 6.9 ± 2.2; respectively, p < 0.001) were 
found to be significantly lower in the IBD group 
than in the control group. Meanwhile, the AoDD 
(28.7 ± 3.8 vs. 2.66 ± 2.6 mm, respectively, 
p < 0.001) values were significantly higher in the 
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Table 3. Pulse-wave tissue Doppler echocardiography measurements of the septal wall.
Variables Controls  
(n = 50)
Total IBD  
patients  
(n = 72)
UC patients  
(n = 56)
CD patients  
(n = 16)
Systolic myocardial wave (S’) [cm/s] 10.6 ± 2.3 8.0 ± 1.4 
(p < 0.001)
8.0 ± 1.5 
(p < 0.001)
8.0 ± 1.3 
(p < 0.001)
Early diastolic myocardial wave (E’) [cm/s] 14.6 ± 3.3 8.2 ± 2.5 
(p < 0.001)
7.8 ± 2.4 
(p < 0.001)
9.4 ± 2.4 
(p < 0.001)
Late diastolic myocardial wave (A’) [cm/s] 10.4 ± 2.4 8.8 ± 1.6 
(p < 0.001)
8.9 ± 1.6 
(p < 0.001)
8.4 ± 1.9 
(p = 0.006)
E’/A’ ratio 1.4 ± 0.4 1.0 ± 0.4 
(p < 0.001)
0.9 ± 0.4 
(p < 0.001)
1.2 ± 0.55 
(p = 0.079)
Myocardial isovolumetric contraction time [ms] 68.0 ± 13.2 78.2 ± 18.3 
(p = 0.001)
78.5 ± 18.7 
(p = 0.001)
77.1 ± 17.5 
(p = 0.031)
Ejection time [ms] 291.1 ± 26.0 268.6 ± 19.9 
(p < 0.001)
268.5 ± 17.4 
(p < 0.001)
269.1 ± 27.6 
(p = 0.005)
Myocardial isovolumetric relaxation time [ms] 65.3 ± 10.6 85.5 ± 15.8 
(p < 0.001)
85.8 ± 15.4 
(p < 0.001)
84.6 ± 17.6 
(p < 0.001)
Myocardial performance index 0.45 ± 0.06 0.61 ± 0.12 
(p < 0.001)
0.61 ± 0.12 
(p < 0.001)
0.6 ± 0.14 
(p < 0.001)
IBD — inflammatory bowel disease; UC — ulcerative colitis; CD — Crohn’s disease
IBD group, although there were no significant 
differences with respect to the AoSD values be-
tween the groups (p = 0.709). A subgroup analy-
sis of the aortic elasticity parameters between the 
UC and CD groups and the controls also showed 
the same results as those observed in the IBD 
group and controls.
Echocardiographic correlates of  
aortic stiffness
The correlations between the echocardio-
graphic measurements on LV tissue Doppler and 
the aortic elasticity parameters are shown in Tables 5 
and 6. There were positive correlations between 
AD and S’ (r= 0.40, p< 0.001), E’ (r = 0.48, 
p < 0.001) and E’/A’ ratio (r = 0.26, p = 0.003) 
and negative correlations between ASt and IVRTm 
(r = –0.43, p < 0.001), the E/E’ ratio (r = –0.37, 
p < 0.001) and MPI (r = –0.44, p < 0.001). In ad-
dition, there were positive correlations between 
ASt and S’ (r = 0.36, p = 0.001), E’ (r = 0.53, p < 
< 0.001) and E’/A’ (r = 0.30, p = 0.001) and negative 
correlations between ASt and IVRTm (r = –0.50, 
p < 0.001), E/E’ (r = –0.38, p < 0.001) and MPI 
(r = –0.56, p < 0.001). The subgroup analysis 
showed similar findings between the UC and 
CD groups with respect to the ASt and LV TDE 
parameters, with the exception of an insignificant 
correlation between AD and E’/A’ in the CD group 
(Table 5). In addition, there were insignificant cor-
relations between ASt and S’, A’ and the E’/A’ ratio 
in the CD group (Table 6).
Table 4. Echocardiographic parameters of aortic elasticity in the study groups.
Variables Controls  
(n = 50)





CD patients  
(n = 16)
Aortic systolic diameter [mm] 30.5 ± 2.7 30.8 ± 3.8 
(p = 0.709)
30.7 ± 3.0 
(p = 0.804)
31.1 ± 4.8 
(p = 0.591)
Aortic diastolic diameter [mm] 26.6 ± 2.6 28.7 ± 3.8 
(p = 0.001)
28.6 ± 3.4 
(p = 0.001)
29.0 ± 5.0 
(p = 0.013)
Aortic strain [%] 15.1 ± 4.5 7.38 ± 2.6 
(p < 0.001)
7.4 ± 2.7 
(p < 0.001)
7.2 ± 2.4 
(p < 0.001)
Aortic distensibility [10–3 cm2 × dyn–1] 6.9 ± 2.2 3.3 ± 1.4 
(p < 0.001)
3.4 ± 1.5 
(p < 0.001)
3.1 ± 1.2 
(p < 0.001)
IBD — inflammatory bowel disease; UC — ulcerative colitis; CD — Crohn’s disease
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Table 5. Correlation between aortic distensibility and left ventricular tissue Doppler echocardiographic 
parameters.
Variables Co-efficient (p value)
Total IBD patients 
(n = 72)
UC patients  
(n = 56)
CD patients  
(n = 16)
Systolic myocardial wave (S’) 0.402 (< 0.001) 0.394 (< 0.001) 0.277 (0.024)
Early diastolic myocardial wave (E’) 0.488 (< 0.001) 0.474 (< 0.001) 0.350 (0.004)
Late diastolic myocardial wave (A’) 0.292 (0.001) 0.302 (0.002) 0.246 (0.046)
E/E’ –0.371 (< 0.001) –0.361 (< 0.001) –0.335 (0.006)
E’/A’ 0.265 (0.003) 0.273 (0.005) 0.124 (0.321)
Myocardial isovolumetric contraction time –0.260 (0.004) –0.251 (0.010) –0.227 (0.067)
Ejection time 0.271 (0.003) 0.262 (0.007) 0.204 (0.101)
Myocardial isovolumetric relaxation time –0.431 (< 0.003) –0.400 (< 0.001) –0.418 (< 0.001)
Myocardial performance index –0.444 (< 0.001) –0.419 (< 0.001) –0.439 (< 0.001)
IBD — inflammatory bowel disease; UC — ulcerative colitis; CD — Crohn’s disease
Discussion
This is the first study designed to determine the 
relationship of AS with the LV function in IBD pa-
tients without known CV risk factors. There are three 
major results of this study: 1) stiffness of the aorta is 
increased in IBD patients, independent of atherogenic 
risk factors, including HT and aortic atherosclerosis; 
2) IBD patients show sub-clinical LV diastolic and 
systolic dysfunction; 3) most importantly, there is 
a significant association between AS and both the 
LV systolic and diastolic function in these patients 
compared with matched healthy controls.
The aortic stiffness observed in IBD patients 
can be explained by several mechanisms. Recent 
studies have reported an association between 
chronic low-grade inflammation and arterial stiffen-
ing [12, 13]. Systemic inflammation thus appears to 
be an emerging causal factor for increased arterial 
stiffness in chronic inflammatory disease states, 
such as systemic lupus erythematosus [12] and 
rheumatoid arthritis [12]. Moreover, it has been 
reported that even acute, mild, transient inflam-
matory stimuli may cause deterioration of the 
elastic properties of large arteries [14]. However, 
the arterial stiffening noted in cases of chronic 
inflammatory disorders may be independent of 
the presence of atherosclerosis and related to 
disease duration [12] and/or, alternatively, present 
as a manifestation of preceding vascular disease. 
Several mechanisms by which a systemic inflam-
matory state can accelerate the atherosclerotic 
process have been suggested. Cytokine-mediated 
damage of the endothelium, immune cell activation 
Table 6. Correlation between aortic strain and left ventricular tissue Doppler echocardiographic  
parameters.
Variables Co-efficient (p value)
Total IBD patients 
(n = 72)
UC patients  
(n = 56)
CD patients  
(n = 16)
Systolic myocardial wave (S’) 0.366 (0.001) 0.362 (< 0.001) 0.206 (0.098)
Early diastolic myocardial wave (E’) 0.531 (< 0.001) 0.522 (< 0.001) 0.374 (0.002)
Late diastolic myocardial wave (A’) 0.275 (0.002) 0.278 (0.004) 0.217 (0.080)
E/E’ –0.383 (< 0.001) –0.379 (< 0.001) –0.336 (0.006)
E’/A’ 0.309 (0.001) 0.330 (0.001) 0.145 (0.246)
Myocardial isovolumetric contraction time –0.364 (< 0.001) –0.359 (< 0.001) –0.331 (0.007)
Ejection time 0.386 (< 0.001) 0.391 (< 0.001) 0.355 (0.003)
Myocardial isovolumetric relaxation time –0.507 (< 0.001) –0.491 (< 0.001) –0.470 (< 0.001)
Myocardial performance index –0.567 (< 0.001) –0.556 (< 0.001) –0.574 (< 0.001)
IBD — inflammatory bowel disease; UC — ulcerative colitis; CD — Crohn’s disease
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and stimulation of the coagulation cascade have all 
been implicated. The onset of IBD seems to be the 
result of a combination of environmental, genetic 
and immunologic factors in which an uncontrolled 
immune response within the intestine leads to the 
development of inflammation in genetically predis-
posed individuals [15]. Dysfunction of the intestinal 
immune system and cross-reactivity against host 
epithelial cells have further been implicated as 
major mechanisms by which inflammation occurs 
[16]. In a study of 70 patients with CD, it was 
shown that more than 20% of the subjects exhibited 
either chronic inflammatory-cell infiltration, acute 
and chronic inflammatory-cell infiltration, oblitera-
tive changes with inflammatory-cell infiltration or 
granulomatous inflammation in walls of the arteries 
or arterioles [17]. In the last decade, it has become 
increasingly evident that chronic systemic inflam-
mation plays a pivotal role in the pathogenesis 
of atherosclerosis [18]. Early atherosclerosis is 
a clinical feature common to several inflammatory 
and immunological diseases [16]. Furthermore, 
findings of an increased carotid intima–media 
thickness (a measurement of the atherosclerotic 
burden), endothelial dysfunction and atherogenic 
alterations in the lipid profiles of patients with IBD 
have fueled the hypothesis suggesting a potential 
increased risk of atherosclerosis-driven vascular 
diseases in cases of IBD [19–21].
Likewise, an increased risk of CV diseases in 
patients with other inflammatory conditions, such 
as rheumatoid arthritis [22], psoriasis [23] and 
systemic lupus erythematous [24], independent of 
traditional CV risk factors, has been established. 
Currently, the reported results for the risk of CV 
disease in the setting of IBD have been ambiguous, 
with some studies revealing an increased risk of 
both ischemic heart disease and cerebrovascular 
accidents and others showing no associations 
[25–28]. Additionally, a few studies have suggested 
that IBD patients have a lower burden for some 
traditional risk factors for CV disease, such as 
HT, DM, dyslipidemia and obesity, and that non-
traditional risk factors may play an important role 
in IBD patients [28, 29].
Coronary artery disease, DM, HT and thy-
roid dysfunction are clinical conditions causing 
increased AS [30]. Therefore, we excluded patients 
having these diseases from our study. Increased 
arterial stiffness gives rise to systolic HT, LV 
hypertrophy and impaired coronary perfusion, re-
sulting in high CV risks. Moreover, increased AS 
is known to be an independent risk factor for CV 
morbidity and mortality [30].
Arterial stiffness can be evaluated using vari-
ous methods, including applanation tonometry, 
PW velocity and transthoracic echocardiography 
(TTE). The PW velocity measured at the carotid 
and femoral arteries is considered to be the gold 
standard measurement of arterial stiffness [6]. 
However, M-mode echocardiography, as used in 
this study to evaluate AS, is a validated and re-
producible method for conducting non-invasive as-
sessments of arterial stiffness. Pulsatile alterations 
in the diameter of the aorta, as well as the degree 
of strain and distensibility, can be evaluated with 
the aid of TTE [31]. The easy availability and low 
costs of this modality are only some advantages 
of this method.
In the present study, the LV systolic and dias-
tolic functions were evaluated using conventional 
echocardiographic techniques, including TDE. 
We used the E/A, E’/A’ and E/E’ ratios, the most 
important parameters, to evaluate the LV diastolic 
function. Moreover, we used MPI and Sm to assess 
the LV systolic function. These TDE parameters 
are less affected by the limiting variables of conven-
tional echocardiographic methods, such as preload, 
afterload, ventricular geometry, BP and heart rate 
[32, 33]. We herein demonstrated that there was 
an increased rate of both systolic and diastolic 
dysfunction in IBD patients compared to the con-
trols. Moreover, the aortic stiffness indices, ASt 
and distensibility were shown to be significantly 
lower in the patients than in the controls.
The findings of this study also showed a close 
association between AS and LV systolic and dias-
tolic dysfunction. LV contractions lead to opening 
of aortic leaflets, which displaces the aortic an-
nulus and generates a force that stretches the 
ascending aorta. The AS observed in IBD patients 
increases the usually ignored component of LV 
preload and results in myocardial stiffness, which 
causes gradual impairment of the LV function. LV 
dysfunction begins with diastolic dysfunction and 
progresses to systolic dysfunction. In our study, 
there was a significant relationship between ASt 
and AD and the E’/A’ ratio, E/E’ ratio, Sm and MPI 
in the patient group.
In the present study, we excluded subjects 
with HT, DM, dyslipidemia, cardiac and pulmonary 
problems and obesity in order to avoid the nega-
tive effects of these variables on the myocardium 
and aorta. A low BMI and lipid levels have been 
previously seen in IBD patients [34–37]. In our 
study, although statistically non-significant, the 
patients had lower BMI values than the controls 
in addition to significantly lower LDL-C levels. 
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Additionally, the number of smoking subjects was 
similar between the groups. We also analyzed 
relatively younger subjects under 50 years of age, 
and the subgroup analysis revealed nearly the same 
findings. Therefore, the abnormal findings of LV 
systolic and diastolic dysfunction and the increased 
AS noted in this study are assumed to be due to 
disease-related factors.
Limitations of the study
Some limitations of this study must be men-
tioned. The first and main limitation of this study 
is that we did not obtain any invasive measure-
ments to evaluate the PP or elasticity of the aorta. 
However, although invasive methods remain the 
gold standard, several reports have demonstrated 
M-mode echocardiography to be a reliable alterna-
tive to such techniques. Indeed, the non-invasively 
calculated measurement of aortic elasticity exhibits 
excellent correlations with indices derived from 
invasive methods [38, 39]. Second, the relatively 
low number of subjects included in this study may 
prevent generalization of the results to all IBD 
patient populations. Therefore, large-scale studies 
are needed to confirm our results. Third, although 
a relatively small number of patients (16%) receiv-
ing immunosuppressive drugs and steroids were 
included in this study, these drugs might have 
negatively affected our results.
Conclusions
In the present study, it was shown that indices 
of AS are independently associated with echo-
cardiographic parameters of the LV systolic and 
diastolic functions in patients with IBD without 
known CV risk factors. Aortic elasticity parameters 
measured using non-invasive echocardiography can 
be beneficial for predicting early CV risks in IBD 
patients. However, future large, prospective longi-
tudinal studies are needed to determine the true 
risk of CV disease in IBD populations and further 
characterize preventive and risk factors.
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